Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN22 | Q9Y2R2 | 1/20 | 0.62 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | LDHA | P00338 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.48 |
| ▸ | HPRT1 | P00492 | 1/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.45 |
| ▸ | PAK1 | Q13153 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29401627 | 0.97 | PTPN22 (0.65) | PTPN22HSD17B10ALDH1A1CYP2A6TSHR | |
| SCHEMBL374807 | 0.97 | PTPN22 (0.65) | PTPN22HSD17B10ALDH1A1CYP2A6TSHR | |
| SCHEMBL1840828 | 0.95 | PTPN22 (0.62) | PTPN22HSD17B10ALDH1A1CYP2A6TSHR | |
| SCHEMBL9060860 | 0.95 | PTPN22 (0.62) | PTPN22HSD17B10ALDH1A1CYP2A6TSHR | |
| SCHEMBL6634384 | 0.91 | PTPN22 (0.58) | PTPN22HSD17B10ALDH1A1CYP2A6TSHR | |
| SCHEMBL8735056 | 0.91 | PTPN22 (0.58) | PTPN22HSD17B10ALDH1A1CYP2A6TSHR | |
| SCHEMBL9510182 | 0.89 | PTPN22 (0.56) | PTPN22HSD17B10ALDH1A1CYP2A6TSHR | |
| SCHEMBL7829341 | 0.89 | PTPN22 (0.56) | PTPN22HSD17B10ALDH1A1CYP2A6TSHR | |
| Sulfur Dioxide SCHEMBL20526198 | 0.89 | PTPN22 (0.56) | PTPN22HSD17B10ALDH1A1CYP2A6TSHR | |
| SCHEMBL4443508 | 0.89 | PTPN22 (0.56) | PTPN22HSD17B10ALDH1A1CYP2A6TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1134226-B1 | Process for producing an optically active ruthenium-phosphine complex and process for producing an optically active alcohol by using the complex | TAKASAGO PERFUMERY CO LTD (JP) | 2007-01-03 | — | — | EP | disclosed |
| US-6596887-B2 | Reacting a ruthenium-phosphine complex with a specific optically active chiral diamine to deactivate one of the enantiomers and with another diamine to activate the other enantiomers | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2003-07-22 | — | — | US | disclosed |
| US-20010039354-A1 | Process for producing an optically active ruthenium-phosphine complex and process for producing an optically active alcohol by using the complex | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2001-11-08 | — | — | US | disclosed |
| EP-1134226-A2 | Process for producing an optically active ruthenium-phosphine complex and process for producing an optically active alcohol by using the complex | Takasago International Corporation (JP) | 2001-09-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010039354-A1 | Process for producing an optically active ruthenium-phosphine complex and process for producing an optically active alcohol by using the complex | DRD4, PNMT, DRD1 | PTPN22 3859/4885HSD17B10 4786/4885ALDH1A1 1040/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.